483 related articles for article (PubMed ID: 17643269)
21. Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999.
Belongia EA; Proctor M; Vandermause M; Ahrabi-Fard S; Knobloch MJ; Keller P; Bergs R; Chyou PH; Davis JP
WMJ; 2000 Aug; 99(5):55-9. PubMed ID: 11043072
[TBL] [Abstract][Full Text] [Related]
22. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy.
Marchese A; Ardito F; Fadda G; Fontana R; Lo Cascio G; Nicoletti G; Speciale AM; Schito GC
Int J Antimicrob Agents; 2005 Jul; 26(1):8-12. PubMed ID: 15967638
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
Brown SD; Farrell DJ; Morrissey I
J Clin Microbiol; 2004 Nov; 42(11):4980-7. PubMed ID: 15528684
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
[TBL] [Abstract][Full Text] [Related]
25. Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.
Simoens S; Verhaegen J; Laekeman G; Peetermans WE
Int J Antimicrob Agents; 2005 Jul; 26(1):62-8. PubMed ID: 15963695
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study.
Reinert RR; Simic S; Al-Lahham A; Reinert S; Lemperle M; Lütticken R
J Clin Microbiol; 2001 Mar; 39(3):1187-9. PubMed ID: 11230456
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.
Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M
Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022
[TBL] [Abstract][Full Text] [Related]
29. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.
Sahm DF; Brown NP; Draghi DC; Evangelista AT; Yee YC; Thornsberry C
Postgrad Med; 2008 Sep; 120(3 Suppl 1):8-15. PubMed ID: 18931466
[TBL] [Abstract][Full Text] [Related]
30. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Appelbaum PC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
[TBL] [Abstract][Full Text] [Related]
31. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
32. Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001.
Ho PL; Que TL; Chiu SS; Yung RW; Ng TK; Tsang DN; Seto WH; Lau YL
Emerg Infect Dis; 2004 Jul; 10(7):1250-7. PubMed ID: 15324545
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
Sahm DF; Brown NP; Thornsberry C; Jones ME
Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
[TBL] [Abstract][Full Text] [Related]
35. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
Johnson DM; Stilwell MG; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.
Adam HJ; Schurek KN; Nichol KA; Hoban CJ; Baudry TJ; Laing NM; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2007 Jan; 51(1):198-207. PubMed ID: 17088485
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
38. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England.
Johnson AP; Sheppard CL; Harnett SJ; Birtles A; Harrison TG; Brenwald NP; Gill MJ; Walker RA; Livermore DM; George RC
J Antimicrob Chemother; 2003 Dec; 52(6):953-60. PubMed ID: 14585858
[TBL] [Abstract][Full Text] [Related]
39. Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.
Van PH; Binh PT; Minh NH; Morrissey I; Torumkuney D
J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i93-102. PubMed ID: 27048586
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary.
Dobay O; Rozgonyi F; Hajdú E; Nagy E; Knausz M; Amyes SG
J Antimicrob Chemother; 2003 Apr; 51(4):887-93. PubMed ID: 12654736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
